← All organizations

Highest phase reached
Phase 3
First clinical trial
Jul 1, 2011Last known activity
Mar 1, 2024
Timeline
2010s
- Jun 1, 2010
Allodynic Therapeutics, LLC— Founded
Drugs by trial phase (3 distinct, 8 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (16)
- NCT05685225Study directorPhase 2Mar 1, 2024
- NCT05685225Lead sponsorPhase 2Mar 1, 2024
- NCT03194555Lead sponsorPhase 2Aug 25, 2017
- NCT03194555Overall official - principal investigatorPhase 2Aug 25, 2017
- NCT03201393Lead sponsorPhase 2Aug 15, 2017
- NCT03201393Overall official - principal investigatorPhase 2Aug 15, 2017
- NCT03185143Lead sponsorPhase 2/Phase 3Jun 27, 2017
- NCT03185143Overall official - principal investigatorPhase 2/Phase 3Jun 27, 2017
- NCT03061734Study directorPhase 2Feb 18, 2017
- NCT06245902OfficialPhase 2Feb 18, 2017
- NCT03061734Lead sponsorPhase 2Feb 18, 2017
- NCT06245902Lead sponsorPhase 2Feb 18, 2017
- NCT01920087Lead sponsorPhase 2/Phase 3Mar 1, 2014
- NCT01415895Lead sponsorPhase 2Jul 1, 2011
- NCT01415895Sponsor investigatorPhase 2Jul 1, 2011
Details
- Founded
- North Miami, FL, US Jun 1, 2010
- Last known activity
- Mar 1, 2024